Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'

E Gremese, G Brondani, L Apollonio… - Annals of the rheumatic …, 2023 - ard.bmj.com
We read with great interest the meta-analysis by Akiyama et al showing that out of 62 studies
with over 300 000 patients with autoimmune diseases, glucocorticosteroids (GC) therapy …

Photoacoustic Imaging of COVID-19 Vaccine Site Inflammation of Autoimmune Disease Patients

J Jo, D Mills, A Dentinger, D Chamberland… - Sensors, 2023 - mdpi.com
Based on the observations made in rheumatology clinics, autoimmune disease (AD)
patients on immunosuppressive (IS) medications have variable vaccine site inflammation …

[HTML][HTML] Pre-existing autoimmunity is associated with increased severity of COVID-19: a retrospective cohort study using data from the National COVID Cohort …

AS Yadaw, B Afzali, N Hotaling, H Sidky, ER Pfaff… - medRxiv, 2023 - ncbi.nlm.nih.gov
Objective: To examine, using data from the National COVID Cohort Collaborative (N3C),
whether patients with pre-existing autoimmune disease (AID) diagnosis and/or …

[HTML][HTML] Immune response to COVID-19 vaccines in people with immunodeficiencies

E Ricotta, M Zendt, FB Castillo, S Kelly, T Saturday… - 2023 - europepmc.org
COVID-19 vaccine research in immune-deficient/disordered people (IDP) has primarily
focused on cancer and organ transplantation populations. We followed 195 IDP with varied …

Characteristics of COVID-19 Patients who Developed Acute Kidney Injury and Its Association with Mortality: A Systematic Review

EK Gianto - Gaceta Médica De Caracas, 2023 - saber.ucv.ve
Introduction: AKI incidence reported in COVID-19 patients is increasing with contradictory
study results about AKI development with increased mortality. This study was conducted to …

Outcomes of COVID-19 and Factors Associated With Its Severity Among Hospitalized Patients With and Without Systemic Rheumatic Disease During the First Wave of …

CH Siegel, JM Choi, D D'Angelo… - JCR: Journal of …, 2023 - journals.lww.com
Methods We conducted a medical records review study including patients aged≥ 18 years
with confirmed SARS-CoV-2 infection hospitalized at 3 NewYork-Presbyterian sites, March 3 …

Attitudes and beliefs towards COVID-19 and COVID-19 vaccination among rheumatology patients in a Los Angeles County safety net clinic

NKZ Ward, S Pal, K Ruddy, S Savvas - BMC rheumatology, 2023 - Springer
Abstract Background The novel Coronavirus disease (COVID-19) pandemic has
represented an evolving global threat with high morbidity and mortality. Patients with …

[PDF][PDF] Neutralising antibody potency against SARS-CoV-2 wild-type and Omicron BA. 1 and BA. 4/5 variants in infliximab and vedolizumab treated patients with …

Z Liu, K Le, X Zhou, JL Alexander, S Lin… - The Lancet …, 2023 - researchgate.net
Background Anti-TNF drugs, such as infliximab, are associated with attenuated antibody
responses after SARS-CoV-2 vaccination. We aimed to determine how the anti-TNF drug …

Impacto da infecção por COVID-19 em pacientes com doenças reumáticas autoimunes

SMS Peralta, KFP Aguinsaca… - … Journal of Health …, 2023 - ojs.brazilianjournals.com.br
Objetivo: Descrever o impacto da infecção por COVID-19 em pacientes com doenças
reumáticas autoimunes. Metodologia: Foi realizado um estudo descritivo não experimental …

COVID-19 VACCINE IN EGYPTIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND OTHER RHEUMATIC DISEASES

FM Aboud, RS Hussein, MM El Bably… - Ain Shams Medical …, 2023 - journals.ekb.eg
Background: There is a huge debate about the COVID vaccination in the rheumatic patients.
Is it safe? Is it effective? COVID vaccine proved to decrease COVID 19 infection in general …